Latest News About Morgan Stanley & Co Inc

Here’s the latest I could gather based on recent public updates.

• Morgan Stanley Newsroom activity: Morgan Stanley and its Investment Management arm have disclosed several 2025–2026 updates, including the sale of an Ohio pharmaceutical manufacturing/distribution facility and the completion of a $400 million CLO transaction in 2025. These items appear in Morgan Stanley’s own newsroom and related regional outlets in early 2026. This indicates active portfolio exits and expansion of lending/asset-management activities, which are typical for a large diversified financial services firm. [Sources reflect newsroom postings and press summaries from Morgan Stanley’s global and regional sites in 2025–2026.]

• Related external coverage: Market-focused outlets carried reports about Morgan Stanley’s CLO activity and real estate investing outcomes during this period, with notes on asset management scale and fundraising activity. These pieces corroborate the firm’s ongoing capital markets and real estate investing initiatives. [Markets/press summaries from financial information services dated 2025–2026.]

• Overall impression: The firm remains a large, diversified bank and asset manager with active deal flow in real estate, CLOs, and corporate financing, consistent with its known business mix. If you need, I can pull the most current press releases or provide a brief timeline of the notable 2025–2026 transactions. [Synthesis from multiple industry news aggregators and the firm’s own newsroom statements.]

Would you like me to fetch the exact press release links and a concise timeline of the 2025–2026 events? I can also tailor this to a specific geography (e.g., U.S. vs. Asia-Pacific) or focus on a particular business line (Real Estate Investing, CLOs, or Institutional Lending).